Hyperuricemia: Pathophysiology, Gout, Kidney Stones & Treatment

Hyperuricemia = serum urate >6.8 mg/dL (saturation point for monosodium urate crystallization).

Etiology: Overproduction vs. Underexcretion

  • Underexcretion (90%): Reduced renal URAT1/GLUT9 transport; diuretics, CKD, metabolic syndrome, alcohol (lactate competes).
  • Overproduction (10%): High purine intake, tumor lysis, myeloproliferative disorders, Lesch-Nyhan (HPRT deficiency).

Clinical Manifestations

  • Gout: MSU crystals in joints → NLRP3 inflammasome → IL-1β → acute monoarthritis (1st MTP classic). Tophi = chronic deposits.
  • Uric Acid Nephrolithiasis: Radiolucent stones; acidic urine promotes.
  • CKD Association: Crystal-independent tubulointerstitial inflammation.

Management

  • Lifestyle: Low purine (organ meats, shellfish, alcohol—especially beer), weight loss, hydration (>2.5 L), limit fructose.
  • Urgent Lowering (flare): NSAIDs, colchicine, glucocorticoids.
  • Chronic Urate-Lowering Therapy (ULT): Allopurinol (xanthine oxidase inhibitor) — start low, titrate to target <6 mg/dL (<5 if tophi). Febuxostat if allopurinol intolerance. Probenecid (uricosuric) if underexcretion + normal renal function.
  • Prophylaxis: Colchicine 0.6 mg daily × 6 mo during ULT initiation.

Urinary Disorders - Related Articles